Healthcare provider profile · identity verified

Jason K Freeburne, ARNP

Nurse Practitioner · CONCORD, NC · NPI 1003986167

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	643	113
Amlodipine Besylate	Amlodipine Besylate	574	73
Levothyroxine Sodium	Levothyroxine Sodium	436	68
Pantoprazole Sodium	Pantoprazole Sodium	411	66
Lisinopril	Lisinopril	350	60
Mirtazapine	Mirtazapine	343	46
Metoprolol Succinate	Metoprolol Succinate	317	50
Omeprazole	Omeprazole	286	59
Divalproex Sodium	Divalproex Sodium	284	55
Quetiapine Fumarate	Quetiapine Fumarate	279	43
Losartan Potassium	Losartan Potassium	240	39
Sertraline Hcl	Sertraline Hcl	237	43
Metformin Hcl	Metformin Hcl	231	61
Tamsulosin Hcl	Tamsulosin Hcl	213	37
Furosemide	Furosemide	202	67
Memantine Hcl	Memantine Hcl	194	24
Trazodone Hcl	Trazodone Hcl	193	41
Escitalopram Oxalate	Escitalopram Oxalate	189	26
Levetiracetam	Levetiracetam	185	23
Donepezil Hcl	Donepezil Hcl	178	33
Olanzapine	Olanzapine	176	31
Metoprolol Tartrate	Metoprolol Tartrate	175	33
Eliquis	Apixaban	172	29
Benztropine Mesylate	Benztropine Mesylate	168	41
Potassium Chloride	Potassium Chloride	167	42
Carvedilol	Carvedilol	161	29
Famotidine	Famotidine	158	24
Duloxetine Hcl	Duloxetine Hcl	152	22
Rosuvastatin Calcium	Rosuvastatin Calcium	147	35
Clopidogrel	Clopidogrel Bisulfate	142	16
Gabapentin	Gabapentin	141	54
Spironolactone	Spironolactone	140	28
Buspirone Hcl	Buspirone Hcl	132	38
Fluoxetine Hcl	Fluoxetine Hcl	132	16
Hydrochlorothiazide	Hydrochlorothiazide	125	29
Loperamide	Loperamide Hcl	114	26
Meloxicam	Meloxicam	108	22
Ibuprofen	Ibuprofen	107	11
Simvastatin	Simvastatin	104	20
Citalopram Hbr	Citalopram Hydrobromide	103	13
Montelukast Sodium	Montelukast Sodium	103	23
Finasteride	Finasteride	91	14
Glipizide	Glipizide	78	15
Hydroxyzine Hcl	Hydroxyzine Hcl	78	20
Allopurinol	Allopurinol	77	16
Bumetanide	Bumetanide	74	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	72	16
Warfarin Sodium	Warfarin Sodium	71	suppressed
Hydralazine Hcl	Hydralazine Hcl	69	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	30
Risperidone	Risperidone	69	26
Midodrine Hcl	Midodrine Hcl	66	suppressed
Alendronate Sodium	Alendronate Sodium	64	suppressed
Lorazepam	Lorazepam	63	21
Clonazepam	Clonazepam	61	18
Divalproex Sodium Er	Divalproex Sodium	61	17
Jardiance	Empagliflozin	61	13
Diclofenac Sodium	Diclofenac Sodium	60	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	suppressed
Baclofen	Baclofen	55	suppressed
Chlorthalidone	Chlorthalidone	54	suppressed
Farxiga	Dapagliflozin Propanediol	54	12
Lansoprazole	Lansoprazole	53	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	11
Amiodarone Hcl	Amiodarone Hcl	52	suppressed
Bupropion Xl	Bupropion Hcl	52	11
Haloperidol	Haloperidol	52	14
Sotalol	Sotalol Hcl	52	suppressed
Tramadol Hcl	Tramadol Hcl	52	24
Carbidopa-Levodopa	Carbidopa/Levodopa	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	26
Myrbetriq	Mirabegron	46	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	12
Prednisone	Prednisone	45	16
Sucralfate	Sucralfate	45	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	42	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	18
Methotrexate	Methotrexate Sodium	41	suppressed
Ondansetron Hcl	Ondansetron Hcl	41	26
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	39	26
Januvia	Sitagliptin Phosphate	39	11
Ramipril	Ramipril	39	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	38	suppressed
Lurasidone Hcl	Lurasidone Hcl	38	11
Metformin Hcl Er	Metformin Hcl	38	suppressed
Fenofibrate	Fenofibrate	37	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Celecoxib	Celecoxib	35	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	35	12
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	33	suppressed
Oxcarbazepine	Oxcarbazepine	33	suppressed
Topiramate	Topiramate	33	suppressed
Jantoven	Warfarin Sodium	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Diazepam	Diazepam	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Methenamine Hippurate	Methenamine Hippurate	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	11
Gemfibrozil	Gemfibrozil	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	24
Xarelto	Rivaroxaban	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Amantadine	Amantadine Hcl	23	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	11
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Brilinta	Ticagrelor	21	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	20	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Linzess	Linaclotide	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Trintellix	Vortioxetine Hydrobromide	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Invega Sustenna	Paliperidone Palmitate	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Pregabalin	Pregabalin	15	suppressed
Valsartan	Valsartan	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Ozempic	Semaglutide	14	suppressed
Paliperidone Er	Paliperidone	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Digoxin	Digoxin	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Easy Touch Safety Pen Needle	Pen Needle, Diabetic, Safety	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nystatin	Nystatin	13	11
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Lamotrigine Er	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error